Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

0.92
Delayed Data
As of Aug 23
 -0.0286 / -3.01%
Today’s Change
0.64
Today|||52-Week Range
4.07
-36.55%
Year-to-Date
3 Stocks We Wouldn't Touch With a 10-Foot Pole
Aug 22 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close0.95
Today’s open0.95
Day’s range0.92 - 0.96
Volume1,750,292
Average volume (3 months)3,832,762
Market cap$453.5M
Dividend yield--
Data as of 08/23/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+74.73%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...-0.06-0.46%
ENTAEnanta Pharmaceutica...+0.11+0.46%
ACRSAclaris Therapeutics...+0.44+2.12%
CXRXConcordia Internatio...-0.12-1.32%
Data as of 08/23/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts

Partner Offers

Search for Jobs